Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 401

1.

Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.

Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C; FRCR net (FRenCh Retina specialists net).

Am J Ophthalmol. 2015 Jul;160(1):17-25.e1. doi: 10.1016/j.ajo.2015.04.013. Epub 2015 Apr 16.

PMID:
25892127
2.

The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.

Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J, Hsu J, Garg SJ; Post-Injection Endophthalmitis Study Team.

Ophthalmology. 2014 Jan;121(1):283-289. doi: 10.1016/j.ophtha.2013.08.037. Epub 2013 Oct 18.

PMID:
24144453
3.

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team.

Ophthalmology. 2011 Oct;118(10):2028-34. doi: 10.1016/j.ophtha.2011.02.034. Epub 2011 Jun 25.

PMID:
21705087
4.

Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.

Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, DeCroos FC, Garg SJ, Hsu J.

Am J Ophthalmol. 2016 May;165:88-93. doi: 10.1016/j.ajo.2016.02.028. Epub 2016 Mar 2.

PMID:
26944277
5.

Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.

Mezad-Koursh D, Goldstein M, Heilwail G, Zayit-Soudry S, Loewenstein A, Barak A.

Retina. 2010 Jul-Aug;30(7):1051-7. doi: 10.1097/IAE.0b013e3181cd47ed.

PMID:
20616683
6.

Endophthalmitis following intravitreal injections.

Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):499-505. doi: 10.1007/s00417-011-1851-1. Epub 2011 Nov 3.

PMID:
22048244
7.

Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.

Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC.

Ophthalmology. 2012 Aug;119(8):1609-14. doi: 10.1016/j.ophtha.2012.02.014. Epub 2012 Apr 4.

PMID:
22480743
8.

Endophthalmitis after intravitreal injection: the importance of viridans streptococci.

Chen E, Lin MY, Cox J, Brown DM.

Retina. 2011 Sep;31(8):1525-33. doi: 10.1097/IAE.0b013e318221594a. Erratum in: Retina. 2011 Nov;31(10):2139.

PMID:
21878800
9.

Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center.

Nentwich MM, Yactayo-Miranda Y, Schwarzbach F, Wolf A, Kampik A, Mino de Kaspar H.

Retina. 2014 May;34(5):943-50. doi: 10.1097/IAE.0000000000000011.

PMID:
24136408
10.

Incidence and Visual Outcomes of Culture-Proven Endophthalmitis Following Dexamethasone Intravitreal Implant.

Stem MS, Todorich B, Yonekawa Y, Capone A Jr, Williams GA, Ruby AJ.

JAMA Ophthalmol. 2017 Apr 1;135(4):379-382. doi: 10.1001/jamaophthalmol.2016.5883.

PMID:
28208166
11.

Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.

Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK.

Br J Ophthalmol. 2013 Apr;97(4):460-5. doi: 10.1136/bjophthalmol-2012-302435. Epub 2013 Feb 6.

PMID:
23390167
12.

Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes.

Simunovic MP, Rush RB, Hunyor AP, Chang AA.

Br J Ophthalmol. 2012 Jun;96(6):862-6. doi: 10.1136/bjophthalmol-2011-301439. Epub 2012 Mar 24.

PMID:
22446145
13.

ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.

Li AL, Wykoff CC, Wang R, Chen E, Benz MS, Fish RH, Wong TP, Major JC Jr, Brown DM, Schefler AC, Kim RY, OʼMalley RE.

Retina. 2016 Jul;36(7):1349-56. doi: 10.1097/IAE.0000000000000901.

PMID:
26655622
14.

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.

Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA.

Retina. 2011 Apr;31(4):662-8. doi: 10.1097/IAE.0b013e31821067c4. Erratum in: Retina. 2012 Jul;32(7):1441.

PMID:
21836400
15.

Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.

Matthews JL, Dubovy SR, Goldberg RA, Flynn HW Jr.

Ophthalmology. 2014 Mar;121(3):702-8. doi: 10.1016/j.ophtha.2013.10.015. Epub 2014 Jan 16.

PMID:
24439760
16.

Outcomes of post-cataract surgery endophthalmitis referred to a tertiary center from local hospitals in the south of China.

Ding Y, Lin M, Liu H, Zhang W, Wang L, Li Y.

Infection. 2011 Oct;39(5):451-60. doi: 10.1007/s15010-011-0138-0. Epub 2011 Jun 28.

PMID:
21710121
17.

Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome.

Somani S, Grinbaum A, Slomovic AR.

Can J Ophthalmol. 1997 Aug;32(5):303-10.

PMID:
9276117
18.

Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.

Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB.

Ophthalmology. 2004 Aug;111(8):1495-503; discussion 1503.

PMID:
15288977
19.

MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.

Garg SJ, Dollin M, Storey P, Pitcher JD 3rd, Fang-Yen NH, Vander J, Hsu J; Post-Injection Endophthalmitis Study Team.

Retina. 2016 Feb;36(2):351-9. doi: 10.1097/IAE.0000000000000694.

PMID:
26200514
20.

An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.

Goldberg RA, Flynn HW Jr, Isom RF, Miller D, Gonzalez S.

Am J Ophthalmol. 2012 Feb;153(2):204-208.e1. doi: 10.1016/j.ajo.2011.11.035.

Supplemental Content

Support Center